Anticholinergic effects of mianserin
- 1 January 1980
- journal article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 6 (sup7) , 132-138
- https://doi.org/10.1185/03007998009114813
Abstract
SummaryThe anticholinergic effects of the tetracyclic antidepressant mianserin (10 mg), the tricyclic amitriptyline (25 mg) and a placebo were studied in a double-blind, randomized, group-comparative trial in 18 healthy young male volunteers. The daily dose of the test preparations was increased gradually from 1 tablet to the full level of the accepted antidepressant dose by Day 6 and maintained until Day 8. Measurements of various parameters indicative for anticholinergic effects were made before medication and on trial Days 2, 4, 6 and 8. Analysis of co-variance showed mianserin to be devoid of significant anticholinergic effects on any of the variables studied. It caused an un-explainable reduction in pupil diameter, tended to increase the distance of the near point of accommodation and increased salivary production as compared with placebo. Amitriptyline reduced saliva production significantly, tended to reduce pupil diameter and increased the distance of the near point. The subjective side-effects ca...Keywords
This publication has 5 references indexed in Scilit:
- Anticholinergic activity of two tricyclic antidepressantsAmerican Journal of Psychiatry, 1978
- Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo.British Journal of Clinical Pharmacology, 1978
- Clinical pharmacology and pharmacokinetics of clonidineClinical Pharmacology & Therapeutics, 1976
- Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illnessPsychopharmacology, 1976
- Class experiment in clinical pharmacology with benzilonium bromide, an anticholinergic drugEuropean Journal of Clinical Pharmacology, 1974